| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |